Potential clinical applications of current and future oral forms of desmopressin
K Everaert, T Holm-Larsen… - Experimental and …, 2024 - spandidos-publications.com
Desmopressin is a synthetic analogue of vasopressin and a selective vasopressin receptor
2 agonist. It was first synthesised in 1967 and utilised for its antidiuretic properties. It is also …
2 agonist. It was first synthesised in 1967 and utilised for its antidiuretic properties. It is also …
Nonopioid Pain Management Pathways for Stone Disease
JJS Cabo, NL Miller - Journal of Endourology, 2024 - liebertpub.com
Introduction: New opioid dependency after urologic surgery is a serious adverse outcome
that is well-described in the literature. Patients with stone disease often require multiple …
that is well-described in the literature. Patients with stone disease often require multiple …
Potential clinical applications of current and future oral forms of desmopressin
T Holm-Larsen, GB Kheir, S Rottey… - Experimental and …, 2024 - search.proquest.com
Desmopressin is a synthetic analogue of vasopressin and a selective vasopressin receptor
2 agonist. It was first synthesised in 1967 and utilised for its antidiuretic properties. It is also …
2 agonist. It was first synthesised in 1967 and utilised for its antidiuretic properties. It is also …